However, costs, the number of injections, and feto-maternal outcomes of insulin and metformin necessitate a study to be conducted in this part of the world to determine the glycemic control and compare the feto-maternal outcomes in metformin, insulin-treated GDM patients. Here, INS is linked to gestational diabetes.